BioPharma Credit PLC (LON:BPCP – Get Free Report)’s stock price reached a new 52-week high on Wednesday . The company traded as high as GBX 74 and last traded at GBX 74, with a volume of 70866 shares traded. The stock had previously closed at GBX 71.10.
BioPharma Credit Price Performance
The stock has a 50-day simple moving average of GBX 70.08 and a 200 day simple moving average of GBX 69.04. The company has a market capitalization of £998.05 million, a PE ratio of 10.73 and a beta of 0.17.
BioPharma Credit Company Profile
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
Featured Stories
- Five stocks we like better than BioPharma Credit
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
